A Study to Investigate DSA Rebound in Patients Treated With Imlifidase Prior to Transplantation

Clinical trial NCT05049850 · TERMINATED

Trial details

NCT number: NCT05049850
Sponsor: Hansa Biopharma AB
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Kidney Transplantation in Highly Sensitized Patients

Start date: 2022-12-16
Primary completion: 2024-02-05
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.